Nation Mar 09 Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration The companies on Monday announced a partnership in which Hims & Hers will sell Novo Nordisk's medications at "self-pay prices."… By Michelle Chapman, Associated Press
Politics Nov 06 WATCH: Trump announces deal to expand coverage, lower costs on obesity drugs President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy. By Tom Murphy, Aamer Madhani, JoNel Aleccia, Associated Press
Health Sep 17 FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes The Food and Drug Administration on Tuesday posted more than 100 letters to various drugmakers and online prescribing companies, including Hims & Hers, which has built a multibillion-dollar business centered around lower-cost versions of blockbuster obesity injections. By Matthew Perrone, Associated Press
Health Jul 28 In the gray world of GLP-1 supplements online, health experts urge caution Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, which can be deceptive. By Hannah Grabenstein